Live tape
Top 8, mentions 7d6,910META1,931 mentions▲ +0.06GOOGL1,428 mentions▲ +0.02NVDA821 mentions▲ +0.09MSFT601 mentions▲ +0.06TSLA568 mentions▲ +0.05SPY532 mentions▲ +0.04MUSE531 mentions▲ +0.06AMZN498 mentions▲ +0.03

Equity · Healthcare

GMED

NYSE

Globus Medical, Inc.

$74.78 −0.30% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Sep 28, 2026

Reddit mentioned GMED 1 times in the 30 days to 29 September 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 29 September 2026.

Price · Chart
Our own end-of-day closes 55 sessions
$90 $70 1 Jul 28 Sep

The line runs $76 on 1 July through $74.78 on 28 September, on a scale from $70 to $90. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of GMED over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 55 sessions over that window: $76 on 1 July 2026 through $74.78 on 28 September 2026.

Market cap $10.0B
P/E (TTM) 19.2
52-week range $55 – $99
Avg volume 106.1K
Mentions · 30d 1

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Sep 28, 2026

GMED · crowd attention × price

Share ↗
Post on X Share on Reddit Share on LinkedIn
1 mentions

Day20 Sep 2026

MENTIONS10–2 / day
PRICE$74.08 · closedMARKET CLOSED · heldSource: Finazon
GMED over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, breaking wherever we hold no close at all, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.per day012usd$72.5$75.0$77.5$80.0$82.531 Aug7 Sep15 Sep22 Sep29 Sep
GMED over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, breaking wherever we hold no close at all, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.31 Aug15 Sep29 Sep
The Distributed Sentinel 29 Sep 2026

GMED drew 1 Reddit mentions over the 30 days to 29 September 2026

This chart in words

The chart plots daily Reddit mentions of GMED over the 30 days to 29 September 2026: 1 in total, busiest on 20 September with 1, and 1 on the last day counted. The line is the daily close over the same window: $81.38 on 31 August, $74.78 on 28 September. Of those days, 13 were trading sessions and the other 17 are hatched on the chart. On 9 of them no session took place, and the last close before it is carried forward rather than plotted; on 8 of them we hold no close at all, which is a gap in our own record rather than a closure we can prove.

Finazon · prior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source

Crowd sentiment on GMED · 30d

n = 1 scored · Method

1 mention of GMED was scored for sentiment in these 30 days, so that one reading IS the sample. A bullish or bearish share of it could only ever read 0% or 100%, which states the sample size and not the crowd — so none is drawn. The chart on this page applies the same 5-mention floor to every day it plots.

Where GMED is discussed

(30d)
r/wallstreetbets 100% 1 +0.16

GMED insider trades

SEC Form 4

GMED has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 12 December 2025.

Date Insider Type Shares Value
12 Dec 2025 Norwalk Leslie V Sell 4,000 $355K
01 Dec 2025 Kline Kyle Senior Vice President, CFO Sell 18,542 $1.67M
25 Nov 2025 Huller Kelly SVP, GC, Corporate Secretary Sell 7,500 $675K
12 Nov 2025 Davidar David D Sell 25,000 $2.15M
11 Nov 2025 ZARRILLI STEPHEN T Sell 25,000 $2.11M
10 Nov 2025 RHOADS ANN D Sell 2,000 $170K
07 Nov 2025 RHOADS ANN D Sell 8,000 $648K
15 Sep 2025 RHOADS ANN D Sell 10,000 $585K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
08 Dec 2025 Paul David C Executive Chairman Option exercise 34,375 $877K
01 Dec 2025 Kline Kyle Senior Vice President, CFO Option exercise 13,542 $788K
25 Nov 2025 Huller Kelly SVP, GC, Corporate Secretary Option exercise 7,500 $195K
12 Nov 2025 Davidar David D Option exercise 25,000 $638K
11 Nov 2025 ZARRILLI STEPHEN T Option exercise 25,000 $1.10M

GMED reported financials

SEC EDGAR XBRL

GMED reported revenue of $2.9B for the fiscal year ended 31 Dec 2025. Net income over the same period was $537.9M.

Figure Reported Period
Revenue $2.9B 31 Dec 2025 fiscal year
Net income $537.9M 31 Dec 2025 fiscal year
Diluted EPS $3.92 31 Dec 2025 fiscal year
Total assets $5.5B 30 Jun 2026 at period end
Total equity $4.8B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

GMED earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $1.10 $790M
31 Mar 2026 Q1 2026 $0.90 $760M
31 Dec 2025 FY 2025 $3.92 $2.94B
30 Sep 2025 Q3 2025 $0.88 $769M
30 Jun 2025 Q2 2025 $1.49 $745M
31 Mar 2025 Q1 2025 $0.54 $598M
31 Dec 2024 FY 2024 $0.75 $2.52B
30 Sep 2024 Q3 2024 $0.38 $626M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

GMED institutional holders

SEC Form 13F

8 of the 45 institutional funds we track reported a GMED position for the quarter ended 30 Jun 2026 — a combined $78.6M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Bridgewater Associates Held (±25%) +6.5% shares 351,974 $27.8M
Renaissance Technologies New position 196,918 $15.6M
Marshall Wace Trimmed −66.5% shares 188,541 $14.9M
GAMCO Investors Held (±25%) −0.0% shares 129,217 $10.2M
Man Group Added +33.4% shares 55,320 $4.4M
AQR Capital Management Trimmed −95.7% shares 36,534 $2.9M
Millennium Management Trimmed −98.2% shares 28,835 $2.3M
D. E. Shaw & Co. Trimmed −70.7% shares 8,300 $656K
Balyasny Asset Management Exited
Citadel Advisors Exited

Source: SEC EDGAR 13F filings

GMED fails-to-deliver

SEC CNS data

On 31 Aug 2026, 2 shares of GMED failed to deliver (about $166) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
31 Aug 2026 2 $166 <0.001%
28 Aug 2026 3 $248 <0.001%
24 Aug 2026 15,609 $1.4M 0.012%
19 Aug 2026 100 $9K <0.001%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in GMED

STOCK Act disclosures

The most recent congressional trade disclosed in GMED is a purchase by Gilbert Ray Cisneros, Jr. (house, CA), dated 19 Aug 2026.

Date Member Type Amount
19 Aug 2026 filed 10 Sep 2026 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $15K–$50K

Source: U.S. House of Representatives financial disclosures

GMED — frequently asked questions

From live data

Is Reddit bullish or bearish on GMED?

Across 1 classified GMED mentions in the last 30 days, 100% read bullish, 0% bearish and 0% neutral. Crowd sentiment is a social signal, not investment advice.

When did GMED last report earnings?

Globus Medical (GMED) last reported earnings on 30 Jun 2026 for Q2 2026, per SEC filings.

What exchange is GMED listed on?

Globus Medical trades on NYSE under the ticker GMED.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.